Overview
Study information
Network: | CAVD |
Grant Affiliation: | Walker: bNabs after Infection and Immunization |
Strategy: | Prophylactic neutralizing Ab |
Study Type: | Antibody Screening |
Species: | Non-Organism Study |
Stage: | Assays Completed |
Study Start Date: | 2014-11-21 |
Study Made Public: | 2016-02-16 |
Title
Monoclonal antibodies from elite controllers who exhibit strong neutralizing antibody breadth
Description
CAVD 469 is an immunogenicity study to develop broadly neutralizing antibodies in HIV infection and following immunization.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
NAb non-standard data